ATHERSYS TO HOST FOURTH QUARTER AND YEAR-END 2012 FINANCIAL RESULTS CALL
Cleveland, OHIO, February 25, 2013 –Athersys, Inc. (Nasdaq: ATHX) today announced it will release its fourth quarter and year-end 2012 financial results at approximately 4:00 PM (Eastern Time) on Tuesday, March 12, 2013, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:
|
Date |
March 12, 2013 |
|
Time |
4:30 p.m. (Eastern Time) |
|
Telephone access: U.S. and Canada |
800-273-1254 |
|
Telephone access: International |
973-638-3440 |
|
Access code |
95456637 |
|
Live webcast |
www.athersys.com, under the Investors section |
A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM (Eastern Time) on March 28, 2013, at the aforementioned URL, or by dialing 800-585-8367 or 855-859-2056 in the U.S. and Canada, from abroad, 404-537-3406, and entering access code 95456637.
About Athersys
Athersys is a clinical stage biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product platform for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas. The Company currently has several clinical stage programs involving MultiStem, including for treating inflammatory bowel disease, ischemic stroke, damage caused by myocardial infarction, and for the prevention of graft-versus-host disease. Athersys has also developed a diverse portfolio that includes other technologies and product development opportunities, and has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions in the United States and Europe to further develop its platform and products. More information is available at www.athersys.com.
News Source : ATHERSYS TO HOST FOURTH QUARTER AND YEAR-END 2012 FINANCIAL RESULTS CALL
More User Press Releases
- ATHERSYS REPORTS FIRST QUARTER 2013 RESULTS
- Athersys to Present at 12th Annual Needham Healthcare Conference
- ATHERSYS TO HOST FIRST QUARTER 2013 FINANCIAL RESULTS CALL
- Athersys Announces Authorization of Stem Cell Clinical Trial for Stroke in the United Kingdom
- ATHERSYS TO PRESENT AT REGEN MED INVESTOR DAY 2013 IN NEW YORK
- Publications Demonstrate Relevance of MultiStem® for Autoimmune Disease, Transplantation and Vascular Disease
- ATHERSYS REPORTS FOURTH QUARTER AND 2012 ANNUAL RESULTS
- Athersys Files Shelf Registration to Replace Expiring S-3 Registration Statement
- ATHERSYS TO PRESENT AT BIOTECH SHOWCASE 2013
- ATHERSYS NAMED TO DELOITTE’S 2012 TECHNOLOGY FAST 500™

This press release is licensed under a Creative Commons Attribution 3.0 Unported License. Read full copyright information here.
Like this site on Facebook
Distribute Press Release
Shopping cart
User login
Search
Bookmark/Search this post
Page View Counter
Primary Menu
- News by Region
- Business
- List of Industries
- Technology
- Aerospace & Defense
- Agriculture & Forestry
- Arts
- Automotive
- Business Services
- Chemicals
- Construction & Maintenance
- Consumer Goods
- Education
- Electrical & Electronics
- Energy
- Entertainment
- Food & Related Products
- General Business
- Government
- Healthcare
- Heavy Industry
- Home
- Industrial Goods & Services
- Industrial Materials
- Medical
- Mining & Drilling
- Publishing & Printing
- Retail
- Society
- Sports
- Supermarkets
- Telecommunications
- Textiles & Nonwovens
- Transportation & Logistics
- Travel & Hospitality
- Wholesale
